Track topics on Twitter Track topics that are important to you
In introducing the FDA’s Drug Competition Action Plan, the commissioner announced his intent to assess ways FDA rules may be misused to create obstacles against generic drug access and competition; the organization plans to hold a meeting on July 18, 2017, to solicit input from the public.“Too many patients are being priced out of the medicines they need,” Scott Gottlieb, MD, commissioner of the FDA, wrote in the FDA’s blog. “While FDA doesn’t have a direct role in drug pricing, we can take steps to help address this problem by facilitating increased competition in the market for prescription drugs through the approval of lower-cost, generic medicines.”
Original Article: FDA commissioner calls for public input on lifting generic barriersNEXT ARTICLE
Pharmacy is the science and technique of preparing as well as dispensing drugs and medicines. It is a health profession that links health sciences with chemical sciences and aims to ensure the safe and effective use of pharmaceutical drugs. The scope of...
In order to become availible to pateints, drugs need to undergo a number of phases of clinical trials to test their efficacy and safty and to then be authorised by the drug approval organistion in each respective country. This is the FDA in the USA and N...